Spain Biotechnology Stock News
Categories
- All
- Editor's Picks
- Stock Market News
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Instant Alerts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
Biotechnology
Laboratorios Farmaceuticos Rovi SA (FRA:41L) Q3 2024 Earnings Call Highlights: Resilient Specialty Pharma and Strategic Shifts
Despite a dip in operating revenue, Rovi SA shows strength in specialty pharma and Okedi sales, while navigating challenges in CDMO and U.S. market strategies. Nov 08, 2024
Biotechnology
Laboratorios Farmaceuticos Rovi SA (STU:41L) Q2 2024 Earnings Call Highlights: Navigating Revenue Declines and Strategic Growth Opportunities
Despite a challenging quarter with decreased revenues, Laboratorios Farmaceuticos Rovi SA (STU:41L) focuses on strategic expansions and product approvals to drive future growth. Oct 09, 2024